Zilia is a health technology company based in Quebec City, Canada, that is revolutionizing the way we care for our sight. Founded by Dr. Patrick Sauvageau, a trained optometrist and visual scientist, and his brother Dominic Sauvageau, a PhD in engineering, Zilia aims to prevent, diagnose, and manage eye diseases in a more effective manner.

With their breakthrough platform, Zilia measures critical biomarkers in the eye using advanced imaging, spectroscopy, and artificial intelligence. This groundbreaking technology generates actionable data about the eye's metabolic activity, allowing for early detection of leading causes of preventable blindness such as glaucoma, diabetic retinopathy, and age-related macular degeneration. Zilia's vision extends beyond eye care, as they intend to develop comprehensive and cutting-edge healthcare solutions for various medical disciplines.

They envision their technology impacting fields like neurology, cardiology, oncology, intensive care, and drug research and development. By using the eye as a window to health, Zilia is dedicated to making a transformative impact in real lives and shaping the future of eye care and beyond. Join them on their remarkable journey to protect and optimize vision for all